Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Contract Value
Not provided
Codes & Classification
Solicitation Number
7599226SN106
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN13
Additional Details
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a presolicitation notice for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program. This initiative seeks to engage small business concerns (SBCs) with robust research and development (R&D) capabilities to address ARPA-H’s mission needs and advance the objectives of the SBIR and STTR programs.
The primary purpose of this procurement is to stimulate technological innovation, strengthen the role of small businesses in meeting federal R&D needs, foster participation by socially and economically disadvantaged and women-owned small businesses, and increase the commercialization of innovations derived from federal R&D. The ultimate goal is to enhance competition, productivity, and economic growth through the successful transition of research outcomes into viable products and solutions.
This opportunity is structured as a Broad Agency Announcement (BAA) and is set aside exclusively for small businesses as defined by SBA standards. Eligible entities must be organized for profit, have a principal place of business in the United States, and meet specific ownership and size requirements (no more than 500 employees, with detailed ownership criteria as outlined in 13 C.F.R. § 121.702). The North American Industry Classification System (NAICS) code applicable to this solicitation is 541715, covering Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The solicitation encompasses several high-impact research topics, each targeting a distinct area of health innovation:
1. **Development of an Annual Test to Inform Women About Their Future Fertility (ARPA-H 01):** Aims to discover new biomarkers and develop an affordable, user-friendly diagnostic test to help women make informed fertility planning decisions.
2. **Versatile Bioadhesives (ARPA-H 02):** Seeks the creation of next-generation bioadhesive platforms capable of sealing, bonding, and repairing tissues in challenging clinical environments, with potential for drug delivery and broad tissue compatibility.
3. **Universal Platform for Living Adaptive Toxin-removal (UNI-PLAT) (ARPA-H 03):** Focuses on developing a synthetic biology platform for programmable microbial functions, initially targeting toxin removal but adaptable to various sectors including environmental remediation and therapeutic discovery.
4. **Breaking Ground: The First Curative, Durable, Non-Surgical Therapy for Endometriosis (ARPA-H 04):** Calls for the development of novel, non-surgical, curative treatments for endometriosis, aiming to reduce or deactivate endometrial implants and prevent lesion growth.
5. **ARPA-H Lineage Topic (ARPA-H 05):** Supports the advancement and commercialization of technologies originating from ARPA-H-funded efforts, providing small businesses with resources to bring these innovations to market.
6. **Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune Disease (ARPA-H 06):** Encourages the development of rapid diagnostic assays for multi-system autoimmune diseases, enabling primary care physicians to diagnose and predict disease manifestations efficiently.
7. **Virtual Human Brain for the Development of Neurosurgical Robotics (ARPA-H 07):** Seeks the creation of a high-resolution, anatomically accurate virtual human brain to advance AI-assisted intracranial microsurgery.
The procurement process is organized into multiple stages, with specific deadlines for solution summaries and full proposals detailed in the solicitation attachments. Amendments to the solicitation have been issued to update submission deadlines, clarify requirements, and revise proposal templates. Interested parties are encouraged to review the latest versions of the solicitation documents, including the "SBIR_STTR_BAA_FY26" and responses to Q&A in Attachment H.
The place of performance for this opportunity is Washington, District of Columbia. The contracting entity is ARPA-H, and all inquiries should be directed to the Business Innovation Division at [email protected].
This presolicitation represents a significant opportunity for innovative small businesses specializing in health-related R&D to contribute to transformative projects with the potential for broad societal impact. Contractors should carefully assess the alignment of their capabilities with the outlined research topics and ensure compliance with all eligibility and submission requirements.
For further details and to access solicitation documents, interested parties should refer to the official notice on SAM.gov (Opportunity ID: 0e6b5119ca2540868b047f155d57ea9d) at https://sam.gov/opp/0e6b5119ca2540868b047f155d57ea9d/view.
Documents11